VIAL

				Route
Abaloparatide	Clinical	80 mcg	Daily	SubQ	Max 2 years (label)	FDA
Afamelanotide	Clinical	16 mg implant	Every 2 months	Implant	Labeled	FDA
AOD-9604	Metabolic	250–300 mcg	Daily	SubQ	8–12 weeks	Research
BPC-157	Repair	250–500 mcg	1–2× daily	SubQ / Oral	4–6 weeks	Research
Bremelanotide	Sexual	0.5–1.75 mg	As needed	SubQ	PRN (labeled max 8/month)	FDA
Cagrilintide	Metabolic	0.3–4.5 mg	Weekly	SubQ	Trial titration	Trial
Cerebrolysin	Cognitive	5–10 mL	5 days/week	IM / IV	10–20 days	Research
CJC / Ipamorelin blend	GH	100/100–200/200 mcg	1–2× daily	SubQ	8–12 weeks	Research
CJC-1295 DAC	GH	2 mg	1–2× weekly	SubQ	8–12 weeks	Research
CJC-1295 no DAC	GH	100–200 mcg	2–3× daily	SubQ	8–12 weeks	Research
Desmopressin	Clinical	10 mcg nasal / 0.1–0.4 mg oral	1–3× daily	Nasal / Oral	Labeled	FDA
Dihexa Advanced	Cognitive	5–20 mg	Daily oral	Oral	Unknown	Research
DSIP	Cognitive	100 mcg	Nightly	SubQ	5–10 nights	Research
Dulaglutide	Metabolic	0.75–4.5 mg	Weekly	SubQ	Titrated, ongoing	FDA
Elamipretide	Longevity	4–40 mg	Daily	SubQ	Trial-defined	Trial
Epithalon	Longevity	5–10 mg	Daily	SubQ	10–20 days, 1–2×/year	Research
Follistatin 344 Advanced	GH	50–100 mcg	Daily	SubQ	10–30 days	Research
FOXO4-DRI Advanced	Longevity	Not established	Experimental	SubQ	Unknown	Research
Fragment 176-191	Metabolic	250–500 mcg	1–2× daily	SubQ	8–12 weeks	Research
GHK-Cu	Repair	1–2 mg	Daily	SubQ / Topical	4–12 weeks	Research
GHRP-2	GH	100–300 mcg	2–3× daily	SubQ	8–12 weeks	Research
GHRP-6	GH	100–300 mcg	2–3× daily	SubQ	8–12 weeks	Research
Glutathione	Immune	200–600 mg	2–3× weekly	IM / IV	Ongoing or pulsed	Research
Gonadorelin	Sexual	100 mcg	Pulsed / diagnostic	SubQ / IV	Protocol-specific	FDA
hCG	Clinical	250–500 IU	2–3× weekly (off-label TRT)	SubQ / IM	Protocol-specific	FDA
Hexarelin Advanced	GH	100–200 mcg	2–3× daily	SubQ	4–6 weeks	Research
Ibutamoren	GH	12.5–25 mg	Daily oral	Oral	8–12 weeks	Trial
IGF-1 LR3 Advanced	GH	20–50 mcg	Daily	SubQ / IM	4–6 weeks	Research
Ipamorelin	GH	200–300 mcg	2–3× daily	SubQ	8–12 weeks	Research
Kisspeptin-10 Advanced	Sexual	1–10 mcg	Research / pulsed	SubQ	Short, specialist	Research
KPV	Repair	200–500 mcg	1–2× daily	SubQ / Oral	4–8 weeks	Research
Liraglutide	Metabolic	0.6–3.0 mg	Daily	SubQ	Titrated, ongoing	FDA
LL-37 Advanced	Immune	50–100 mcg	Daily	SubQ	2–4 weeks	Research
Melanotan II Advanced	Sexual	250–500 mcg	Daily then 1–2×/week	SubQ	Until tan, then maintenance	Research
MOTS-c	Metabolic	5–10 mg	2–3× weekly	SubQ	4–6 weeks	Research
N-Acetyl Semax Amidate	Cognitive	200–400 mcg	1–2× daily	Nasal	5–14 days	Research
Noopept	Cognitive	10–30 mg	1–2× daily	Oral / Nasal	1–3 months	Research
Octreotide	Clinical	50–200 mcg	2–3× daily	SubQ / IM	Labeled, ongoing	FDA
Oxytocin	Sexual	10–24 IU nasal	PRN / labeled	Nasal / IV	PRN	FDA
P21	Cognitive	100–300 mcg	Daily	Nasal / SubQ	4–8 weeks	Research
PEG-MGF Advanced	GH	200–400 mcg	2–3× weekly	SubQ / IM	4–8 weeks	Research
Pinealon	Cognitive	100–200 mcg	Daily	SubQ / Oral	10–20 days	Research
Pramlintide	Metabolic	15–120 mcg	With meals	SubQ	Labeled, ongoing	FDA
Retatrutide Advanced	Metabolic	2–12 mg	Weekly	SubQ	Trial titration	Trial
Selank	Cognitive	250–500 mcg	1–2× daily	Nasal	2–3 weeks	Research
Semaglutide	Metabolic	0.25–2.4 mg	Weekly	SubQ / Oral	Titrated, ongoing	FDA
Semax	Cognitive	200–600 mcg	1–2× daily	Nasal	5–14 days	Research
Sermorelin	GH	200–300 mcg	Nightly	SubQ	3–6 months	Research
Setmelanotide	Metabolic	1–3 mg	Daily	SubQ	Labeled, ongoing	FDA
Somatropin	GH	0.2–0.6 mg	Daily	SubQ	Labeled, ongoing	FDA
Survodutide	Metabolic	0.6–4.8 mg	Weekly	SubQ	Trial titration	Trial
TB-500	Repair	2–2.5 mg	2× weekly (load)	SubQ / IM	4–6 weeks load	Research
Teriparatide	Clinical	20 mcg	Daily	SubQ	Max 2 years (label)	FDA
Tesamorelin	GH	2 mg	Daily	SubQ	Ongoing (labeled)	FDA
Thymalin	Immune	10 mg	Daily	IM / SubQ	10 days, 1–2×/year	Research
Thymosin α1	Immune	1.6 mg	2× weekly	SubQ	4–12 weeks	Research
Thymosin β4	Repair	2.5–5 mg	2–3× weekly	SubQ	4–8 weeks	Trial
Tirzepatide	Metabolic	2.5–15 mg	Weekly	SubQ	Titrated, ongoing	FDA
VIP Advanced	Immune	50 mcg	4× daily nasal	Nasal	1–6 months (protocol-specific)	Trial